NDC codes

FDA NDC Directory
Product NDC (as listed)55292-410Labeler and product segments. Claims need a package NDC.
Product NDC at billing width55292-0410Add the package segment from the table below.
Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC11-digit (billing)PackageCopy
55292-410-0555292041005552920410051 BOTTLE, GLASS in 1 BOX (55292-410-05) / 5 mL in 1 BOTTLE, GLASSMarketed from Aug 19, 2020

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary)
Cystadrops
Generic name (nonproprietary)
cysteamine hydrochloride
Active ingredients
Cysteamine hydrochloride — 3.5 mg/mL
Dosage form
Solution
Route
Ophthalmic
Labeler
RECORDATI RARE DISEASES, INC.NDC labeler code 55292
Product type
Prescription drug
Marketing category
NDA — New Drug ApplicationApplication NDA 211302
Marketing start
Listing expires
Other FDA classes
Cystine Disulfide Reduction (Mechanism)
Identifiers
Product ID 55292-410_34dba967-28b4-4fc8-876d-2e30d32a0f95SPL ID 34dba967-28b4-4fc8-876d-2e30d32a0f95SPL set ID 5d2bcce3-9b89-4141-aeb7-db00449047f5UNII IF1B771SVB
Pharmacologic class
Cystine Depleting Agent

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Ophthalmic products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N455292041005 followed by a unit qualifier and the quantity

Package 55292-0410-05. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective .

Indications (excerpt from the label)

CYSTADROPS is a cystine-depleting agent indicated for the treatment of corneal cystine crystal deposits in adults and children with cystinosis. CYSTADROPS is a cystine-depleting agent indicated for the treatment of corneal cystine crystal deposits in adults and children with cystinosis. ( 1 )

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 55292-410

What is NDC 55292-410?
55292-410 is the product NDC for Cystadrops (cysteamine hydrochloride), Cysteamine hydrochloride 3.5 mg/mL solution, listed with the FDA by RECORDATI RARE DISEASES, INC.. It has 1 package NDC, shown above in 10- and 11-digit form.
What drug is associated with this NDC?
Cystadrops (Cysteamine hydrochloride).
What is the active ingredient?
Cysteamine hydrochloride.
Who is the labeler?
RECORDATI RARE DISEASES, INC., NDC labeler code 55292. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Cystadrops?
None: this is the only finished product listed under this name.
Is there a related HCPCS / J-code?
Not in Med-Code's curated HCPCS directory. See Billing references above.

Free account

Log in to keep searching

You’ve used your 3 free searches. Med-Code is free: log in or create a free profile to keep looking up NDCs, J-codes and drugs.

Create a free profileLog in